Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: A population based cohort study

Annals of the Rheumatic Diseases

Volumn 62, Issue 12, 2003, Pages 1185-1188

  Feltelius, N ^a,b   Ekbom, A ^b   Blomqvist, P ^b,c  

^a MEDICAL PRODUCTS AGENCY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOMODULATION; KIDNEY CANCER; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PELVIS CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; RECTUM CANCER; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SWEDEN;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; POISSON DISTRIBUTION; RISK FACTORS; SPONDYLITIS, ANKYLOSING; SWEDEN;

EID: 0345490901     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2002.004721     Document Type: Article

References (28)

1. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11.
2. Radis CD, Kahl LE, Baker GL, Wasko MC, Cash JM, Gallatin A, et al. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. Arthritis Rheum 1995;38:1120-7.
3. Hjelmstrom P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 2001;69:331-9.
4. Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 1998;317:180-1.
5. Ekbom A. Risk of cancer in ulcerative colitis. J Gastrointest Surg 1998;2:312-13.
6. Bouros D, Hatzakis K, Labrakis H, Zeibecoglou K. Association of malignancy with diseases causing interstitial pulmonary changes. Chest 2002;121:1278-89.
7. Kerr HE, Sturrock RD. Clinical aspects, outcome assessment, disease course, and extra-articular features of spondyloarthropathies. Curr Opin Rheumatol 1999;11:235-7.
8. Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol 2001;13:265-72.
9. Sesma L, Montserrat V, Lamas JR, Marina A, Vasquez J, Lopez de Castro JA. The peptide repertoires of HLA-B27 subtypes differentially associated to spondylarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions. Biol Chem 2002;277:16744-9.
10. Weiss HA, Darby SC, Doll R. Cancer mortality following x-ray treatment for ankylosing spondylitis. Int J Cancer 1994;59:327-38.
11. Jonson E. Indikationer för röntgenbehandling vid reumatiska sjukamar. Svenska Läkartidningen 1947;44:2104-13.
12. Dougados M, Dijkmans B, Khan M, Maksymowych W, Van Der Linden S, Brand J. Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 2002;61(suppl III):iii40-50.
13. Brandt J, Haibel H, Reddig J, Sieper J, Braun J. Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab. J Rheumatol 2002;29:118-22.
14. Spetz CL, Carlsson CL, Engqvist M, Forsberg L, Aberg A, Akesson LO, et al. Reintroduction of social security numbers gives better basis for evaluation. The patient registry is open for research. Lakartidningen 1996;93:1844-7, [In Swedish].
15. Centre for Epidemiology. Cancer incidence in Sweden 1996. Centre for Epidemiology, Stockholm, Sweden: The National Board of Health and Welfare, 1998.
16. Centre for Epidemiology. Causes of death 1996. Centre for Epidemiology, Stockholm, Sweden: The National Board of Health and Welfare, 1998.
17. Nyrén O, McLoughlin JK, Gridley G, Ekbom A, Johnell O, Fraumeni JF Jr, et al. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst 1995;87:28-33.
18. de Faire U, Friberg L, Lorich U, Lundman T. A validation of cause of death certification in 1156 deaths. Acta Med Scand 1976;200:223-8.
19. Sundman L, Jakobsson S, Nyström L, Rosén M. A validation of cause of death certification for ischemic heart disease in two Swedish municipalities. Scand J Prim Health Care 1988;6:205-11.
20. Rothman KJ. Modern epidemiology, 2nd ed. Philadelphia: Lippincott-Raven, 1998.
21. Nomura AMY, Kolonel LN. Prostate cancer: a current perspective. Epidemiol Rev 1991;13:200-27.
22. Rosenberg L, Louik C, Shapiro S. Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer 1998;82:2326-33.
23. Thun MJ. Aspirin, NSAIDs and digestive tract cancers. Cancer Metastatis Rev 1994;13:269-77.
24. Shiff SJ, Koutsos MI, Qiao L, Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res 1996;222:179-88.
25. Ligumsky M, Sestieri M, Karmeli F, Zimmerman J, Okon E, Rachmilewitz D. Rectal administration of nonsteroidal antiinflammatory drugs. Effect on rat gastric ulcerogenicity and prostaglandin E2 synthesis. Gastronterology 1990;98(Pt 1):1245-9.
26. Tiwana H, Wilson C, Walmsley RS, Wakefield AJ, Smith MS, Cox NL, et al. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Rheumatol Int 1997;17:11-16.
27. Toivanen P, Hansen DS, Mestre F, Lehtonen L, Vaahtouvo J, Vehma M, et al. Somatic serogroups, capsular types, and species of fecal Klebsiella in patients with ankylosing spondylitis. J Clin Microbiol 1999;37:2808-12.
28. Feltelius N, Hvatum M, Brandtsaeg P, Hallgren R. Increased jejunal secretory IgA and IgM in ankylosing spondylitis: normalization after treatment with sulfasalazine. J Rheumatol 1994;21:2076-81.